SHOCKWAVE MEDICAL INC (SWAV)

US82489T1043 - Common Stock

325.63  +3.02 (+0.94%)

After market: 325 -0.63 (-0.19%)

News Image
2 days ago - Investor's Business Daily

Shockwave Medical Stock Sees Relative Strength Rating Ride Higher

On Wednesday, Shockwave Medical stock got a positive adjustment to its Relative Strength (RS) Rating, from 90 to 94.

News Image
3 days ago - Shockwave Medical, Inc.

Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference

SANTA CLARA, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of...

News Image
13 days ago - The Motley Fool

3 Stocks That Could Create Lasting Generational Wealth

These three well-established growth stocks could be on the way to something much bigger.

News Image
16 days ago - Chartmill

NASDAQ:SWAV qualifies as a high growth stock and is consolidating.

SHOCKWAVE MEDICAL INC (NASDAQ:SWAV) qualifies as a high growth stock and is consolidating.

News Image
a month ago - Investor's Business Daily

ServiceNow And This AI Play Lead 5 Stocks Near Buy Points

Four recent big earnings movers also are on this week's watchlist.

News Image
a month ago - Investor's Business Daily

Broadcom, Target, MongoDB And Jobs Data: Investing Action Plan

A big stock market week for AI and retail with Broadcom, MongoDB, Target and Macy due to report. Jobs data could set the Fed's rate cut tone.

News Image
a month ago - Investor's Business Daily

General Motors, Celsius Lead Five Non-AI Stocks Near Buy Points

Turnaround play GM and energy drink maker Celsius lead this watchlist.

News Image
a month ago - The Motley Fool

Shockwave Medical (SWAV) Q4 2023 Earnings Call Transcript

SWAV earnings call for the period ending December 31, 2023.

News Image
a month ago - Seeking Alpha

ShockWave Medical GAAP EPS of $1.16 beats by $0.26, revenue of $203M beats by $3.55M (NASDAQ:SWAV)

ShockWave Medical reports Q4 2023 financial results, beating EPS and revenue expectations.

News Image
a month ago - Shockwave Medical, Inc.

Shockwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results

SANTA CLARA, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of...

News Image
2 months ago - Seeking Alpha

Shockwave Medical names Renee Gaeta as its CFO (NASDAQ:SWAV)

Shockwave Medical (SWAV) said it has appointed Renee Gaeta as its CFO, effective February 5, 2024. Gaeta, who most recently served as the finance chief at Ek

News Image
2 months ago - Shockwave Medical, Inc.

Shockwave Medical Appoints Renee Gaeta as Chief Financial Officer

SANTA CLARA, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of...

News Image
3 months ago - Shockwave Medical, Inc.

Shockwave Medical Provides Quarterly Earnings Release Dates for 2024

SANTA CLARA, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) -- January 8, 2024 – Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and...

News Image
3 months ago - Shockwave Medical, Inc.

Shockwave Medical to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

SANTA CLARA, Calif., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of...

News Image
4 months ago - Shockwave Medical, Inc.

Shockwave Medical to Participate in the Piper Sandler 35th Annual Healthcare Conference

SANTA CLARA, Calif., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment cardiovascular disease, announced today that the company will be participating in the Piper Sandler 35th Annual Healthcare Conference, which is being held from Tuesday, November 28 to Thursday, November 30, 2023 in New York, NY.

News Image
5 months ago - Seeking Alpha

MedTech stocks gain after Novo Nordisk weight loss drug data

MedTech stocks rally after Novo Nordisk (NVO) disappoints with Phase 3 cardiovascular data for its weight loss therapy, Wegovy. Read more here.